Celebrating our 10th anniversary – Unlock our special offer today

Reynolds prepares to appeal against US FDA denial of Vuse menthol PMTAs

RJ Reynolds Vapor Company plans to challenge the US Food and Drug Administration (FDA)’s rejection of its Vuse menthol vape cartridges, joining a judicial fight that has had mixed results for other companies.

Reynolds will ask an appeals court to stay the FDA’s decision to deny two pre-market tobacco product applications (PMTAs) submitted for the company’s Vuse Vibe Tank Menthol 3% and its Vuse Ciro Cartridge Menthol 1.5%. The promised legal challenge comes amid conflicting opinions about the FDA’s rejection of Reynolds’s PMTAs and a legal landscape that has seen some companies win and others lose.

Read full article
I'm already a subscriber
Author default picture


This article was written by one of ECigIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual vaping markets. For a full list, please see our Who We Are page.

Our Key Benefits

The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization